New diagnostic test by which to detect pancreatic cancer at early stages, should be a safe and effective weapon in the arsenal of oncologists. It developed by Japanese scientists.
Scientists from the Japanese Kobe University have created a test that uses a metabolic analysis - the study of low-molecular metabolic profiles of living cells. The test determines the level of metabolites in the blood of a patient with pancreatic cancer by gas chromatography-mass spectrometry. Clinical trials conducted on healthy and ill patients.
By experiments were randomly selected 43 men having cancer, pancreatic cancer, and 42 healthy individuals. There is also a 23 experiments Bring a patient with chronic pancreatitis. Analyses showed the presence of elevated levels of metabolites in the blood 18 in victims of pancreatic cancer as compared to healthy individuals. These studies are published in the journal Cancer Epidemiology, Biomarkers & Prevention.
"Although the specific surgical procedures are sometimes successful, more than 80% of the victims of this type of cancer already have incurable its form at the time of diagnosis, - said study author Dr. Masaru Yoshida. - Modern methods of diagnosis, including collection of blood, ultrasound and endoscopy are not suitable for early cancer detection. We urgently need something better. " (READ MORE)
Industry News
Go back to the main page
Немає коментарів:
Дописати коментар